4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-22-006278
Head of Pharm Ops and Tech gave up 110 shares (to pay taxes)
- Head of Pharm Ops and Tech acquired 371 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2022-02-18 | Option exercise | +371 | 1,767.89 | D: show line 1 in the form | ||
| Murphy Nicole Head of Pharm Ops and Tech | 2022-02-18 | Shares withheld for taxes | −110 | $209.79 | $23,077 | 1,657.89 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2022-02-18 | Option exercise · Restricted Stock Unit | −371 | 2,349 | D: show line 3 in the form | |||||
| Murphy Nicole Head of Pharm Ops and Tech | 2022-02-18 | Other disposition · Restricted Stock Unit | −535 | 1,814 | D: show line 4 in the form |
Loading xslF345X03/form4.xml…